Cartesian Therapeutics, Inc.
RNACNASDAQHealthcare● Active
$5.86
+$0.02(+0.34%)
Market Cap$172175590
P/E Ratio—
52W High$15.57
52W Low$5.6
Cartesian Therapeutics, Inc.（RNAC）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · RNAC · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.80M | $38.91M | $26.00M | $110.78M | $85.08M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $2.04M | $0.00M |
| Gross Profit | $2.80M | $38.91M | $26.00M | $108.74M | $85.08M |
| Gross Margin %(computed) | 100.00% | 100.00% | 100.00% | 98.16% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $58.03M | $45.10M | $71.26M | $72.38M | $68.74M |
| G&A Expenses | $31.47M | $30.13M | $40.45M | $23.86M | $20.94M |
| Total Operating Expenses | $89.50M | $82.81M | $112.42M | $94.20M | $89.67M |
| Operating Income | ($86.70M) | ($43.90M) | ($86.42M) | $14.54M | ($4.60M) |
| Operating Margin %(computed) | — | -112.81% | -332.32% | 13.12% | -5.40% |
| Interest Income | $6.58M | $7.39M | $4.96M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $2.83M | $3.03M | $2.84M |
| Income Before Tax | ($139.50M) | ($77.14M) | ($238.71M) | $34.77M | ($9.72M) |
| Income Tax Expense | ($9.19M) | $0.29M | ($19.00M) | ($0.61M) | $15.97M |
| Net Income | ($130.30M) | ($77.42M) | ($219.71M) | $35.38M | ($25.69M) |
| Net Margin %(computed) | — | -198.97% | -844.91% | 31.94% | -30.19% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-5.02 | $-2.99 | $-49.76 | $7.33 | $-6.74 |
| Wtd Avg Shares | 25.97M | 25.91M | 5.17M | 4.02M | 3.18M |
| EBITDA | ($86.70M) | ($75.99M) | ($235.03M) | $39.84M | ($5.16M) |
| EBITDA Margin %(computed) | — | -195.27% | -903.84% | 35.96% | -6.06% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Cartesian Therapeutics, Inc.
关于Cartesian Therapeutics, Inc.（RNAC）损益表
Cartesian Therapeutics, Inc.（RNAC）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，RNAC实现营收$0.00B，毛利润$0.00B（毛利率100.00%），净利润($0.13B)（净利率-4658.63%）。
常见问题
RNAC · 4 问Cartesian Therapeutics, Inc.（RNAC）2025财年营收为$0.00B，同比down92.8%。
RNAC revenueRNAC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08